{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Gram Negative Levofloxacin",
        "VITEK 2 AST-GN Levofloxacin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K072038",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041982"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "September 12, 2007",
    "Summary Letter Received Date": "July 25, 2007",
    "Submission Date": "July 20, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Levofloxacin"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Gram-negative bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination",
        "Automated incubation and reading"
    ],
    "Methodologies": [
        "Broth microdilution",
        "Automated antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Gram Negative Levofloxacin antimicrobial susceptibility reagent for use on VITEK 2 systems",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of specified Gram-negative organisms with VITEK 2 and VITEK 2 Compact Systems as an aid in determining in vitro susceptibility to levofloxacin.",
    "fda_folder": "Microbiology"
}